Dhanvantri Jeevan Rekha Ltd
₹ 24.5
0.00%
11 Dec
- close price
About
Incorporated in 1993, Dhanvantri Jeevan Rekha
Ltd provides Medical and Health-care Services.[1]
Key Points
- Market Cap ₹ 10.0 Cr.
- Current Price ₹ 24.5
- High / Low ₹ 35.9 / 16.5
- Stock P/E 100
- Book Value ₹ 24.5
- Dividend Yield 0.00 %
- ROCE 5.82 %
- ROE 5.20 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
- Stock is trading at 1.00 times its book value
- Debtor days have improved from 36.9 to 29.0 days.
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- The company has delivered a poor sales growth of 4.46% over past five years.
- Promoter holding is low: 19.6%
- Company has a low return on equity of 1.61% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Healthcare Services Healthcare Service Provider
Loading peers table ...
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 7.26 | 7.97 | 9.26 | 11.16 | 13.74 | 16.84 | 18.21 | 9.78 | 16.77 | 17.68 | 20.46 | 22.65 | 22.88 | |
| 5.93 | 6.44 | 7.81 | 9.53 | 11.89 | 15.61 | 17.55 | 10.53 | 15.27 | 17.10 | 19.62 | 21.93 | 22.58 | |
| Operating Profit | 1.33 | 1.53 | 1.45 | 1.63 | 1.85 | 1.23 | 0.66 | -0.75 | 1.50 | 0.58 | 0.84 | 0.72 | 0.30 |
| OPM % | 18.32% | 19.20% | 15.66% | 14.61% | 13.46% | 7.30% | 3.62% | -7.67% | 8.94% | 3.28% | 4.11% | 3.18% | 1.31% |
| 0.21 | 0.44 | 0.31 | -0.11 | 0.14 | 0.12 | 0.16 | 0.18 | 0.21 | 0.24 | 0.29 | 0.41 | 0.40 | |
| Interest | 0.01 | 0.08 | 0.08 | 0.18 | 0.22 | 0.11 | 0.04 | 0.02 | 0.02 | 0.01 | 0.01 | 0.01 | 0.00 |
| Depreciation | 0.67 | 0.36 | 0.27 | 0.37 | 1.10 | 1.13 | 1.10 | 1.04 | 1.02 | 0.96 | 0.87 | 0.56 | 0.55 |
| Profit before tax | 0.86 | 1.53 | 1.41 | 0.97 | 0.67 | 0.11 | -0.32 | -1.63 | 0.67 | -0.15 | 0.25 | 0.56 | 0.15 |
| Tax % | 39.53% | 29.41% | 32.62% | 43.30% | -7.46% | 63.64% | -15.62% | -12.88% | 28.36% | 46.67% | 36.00% | 8.93% | |
| 0.52 | 1.07 | 0.95 | 0.55 | 0.73 | 0.05 | -0.26 | -1.42 | 0.49 | -0.22 | 0.17 | 0.51 | 0.10 | |
| EPS in Rs | 1.27 | 2.61 | 2.32 | 1.34 | 1.78 | 0.12 | -0.63 | -3.46 | 1.20 | -0.54 | 0.41 | 1.24 | 0.25 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 4% |
| 3 Years: | 11% |
| TTM: | 5% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | -6% |
| 5 Years: | 32% |
| 3 Years: | 1% |
| TTM: | -83% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 2% |
| 5 Years: | 31% |
| 3 Years: | 20% |
| 1 Year: | 11% |
| Return on Equity | |
|---|---|
| 10 Years: | 2% |
| 5 Years: | -1% |
| 3 Years: | 2% |
| Last Year: | 5% |
Balance Sheet
Figures in Rs. Crores
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 4.15 | 4.15 | 4.15 | 4.15 | 4.15 | 4.15 | 4.15 | 4.15 | 4.15 | 4.15 | 4.15 | 4.15 | 4.15 |
| Reserves | 2.50 | 4.29 | 5.25 | 5.79 | 6.52 | 6.57 | 6.30 | 4.88 | 5.37 | 5.15 | 5.32 | 5.98 | 5.90 |
| 0.09 | 0.00 | 0.00 | 1.94 | 1.95 | 0.10 | 0.10 | 0.07 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| 1.70 | 2.52 | 3.29 | 4.53 | 3.79 | 4.53 | 4.30 | 4.76 | 4.84 | 4.56 | 5.55 | 4.65 | 5.66 | |
| Total Liabilities | 8.44 | 10.96 | 12.69 | 16.41 | 16.41 | 15.35 | 14.85 | 13.86 | 14.36 | 13.86 | 15.02 | 14.78 | 15.71 |
| 4.57 | 5.05 | 7.80 | 12.07 | 12.28 | 11.44 | 10.68 | 9.72 | 8.85 | 8.54 | 8.14 | 8.41 | 8.80 | |
| CWIP | 0.00 | 1.44 | 0.00 | 0.00 | 0.00 | 0.12 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| 3.87 | 4.47 | 4.89 | 4.34 | 4.13 | 3.79 | 4.17 | 4.14 | 5.51 | 5.32 | 6.88 | 6.37 | 6.91 | |
| Total Assets | 8.44 | 10.96 | 12.69 | 16.41 | 16.41 | 15.35 | 14.85 | 13.86 | 14.36 | 13.86 | 15.02 | 14.78 | 15.71 |
Cash Flows
Figures in Rs. Crores
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.21 | 0.80 | 1.32 | 3.52 | 0.89 | 1.27 | 1.38 | -0.35 | 1.05 | -0.39 | 3.03 | -0.29 | |
| -1.27 | -1.41 | -1.33 | -4.00 | -0.57 | -0.31 | -0.14 | 0.00 | -0.06 | -0.56 | -0.39 | -0.66 | |
| 0.00 | 0.42 | 0.31 | 0.87 | -0.21 | -1.96 | -0.04 | -0.05 | -0.09 | 0.00 | 0.00 | 0.00 | |
| Net Cash Flow | -0.06 | -0.18 | 0.30 | 0.40 | 0.11 | -1.00 | 1.19 | -0.40 | 0.90 | -0.95 | 2.64 | -0.95 |
Ratios
Figures in Rs. Crores
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 16.09 | 15.11 | 20.50 | 11.45 | 17.80 | 22.32 | 9.02 | 39.93 | 37.22 | 50.58 | 31.22 | 29.01 |
| Inventory Days | 11.70 | 17.77 | 11.99 | |||||||||
| Days Payable | 0.00 | 0.00 | 0.00 | |||||||||
| Cash Conversion Cycle | 16.09 | 15.11 | 20.50 | 11.45 | 29.50 | 40.09 | 21.00 | 39.93 | 37.22 | 50.58 | 31.22 | 29.01 |
| Working Capital Days | 68.37 | 66.86 | 56.76 | -35.32 | -26.83 | -17.34 | -32.27 | -53.37 | -25.47 | -3.10 | -32.29 | -16.60 |
| ROCE % | 14.04% | 19.76% | 16.70% | 14.94% | 7.27% | 1.88% | -2.62% | -16.39% | 7.41% | -1.49% | 2.77% | 5.82% |
Documents
Announcements
- Announcement under Regulation 30 (LODR)-Newspaper Publication 16 Nov
- RESULT FOR THE HALF YEAR ENDING SEPT 2025 14 Nov
-
Board Meeting Outcome for Board Meeting For The Quterly Result
14 Nov - Board approved un-audited results for quarter/half-year ended 30 Sep 2025 (meeting 14 Nov 2025).
-
Board Meeting Intimation for BOARD MEETING TO BE HELD ON 14.11.2025
6 Nov - Board meeting on 14 Nov 2025 to approve Q2 unaudited results for quarter ended 30 Sep 2025; trading window closed.
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 14 Oct
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2010
from bse
Business Overview:[1][2]
DJRL runs an NABH-accredited hospital by the name of Dhanvantri Hospital and provides a varied range of patient care and super specialty services, and other diagnostic services in Meerut. It offers specialized therapy & support, diagnosis & investigation, and medical treatment & surgery.